Cambridge Researchers Develop Sustainable Method for Chiral Molecules

Researchers at the University of Cambridge synthesized enantioenriched atropisomers through a process called biocatalytic deracemization ^[1].

This breakthrough provides a more efficient and sustainable method for producing chiral molecules, which are essential components in various chemical and pharmaceutical applications. By reducing the waste associated with traditional synthesis, the method addresses a long-standing challenge in chemical manufacturing.

The research team utilized an engineered enzyme to selectively convert a racemic mixture into its desired enantiomer ^[2]. This process allows scientists to isolate specific molecular orientations that are often difficult to separate using standard chemical means. The focus of the study remained on atropisomers ^[1], a class of molecules where chirality results from hindered rotation around a single bond.

"This biocatalytic approach offers a sustainable and scalable route to enantioenriched atropisomers," said Dr. Emily Carter, the lead author of the study ^[2].

According to the research team, the method leverages the precision of biological catalysts to achieve results that were previously difficult to scale. The team said that the process enables the production of complex chiral molecules with high efficiency ^[3].

Traditionally, creating these molecules required expensive catalysts or multi-step purification processes that generated significant chemical byproduct. The new approach replaces these harsh conditions with an enzymatic process that operates under milder environment. This shift not only lowers the environmental impact, but also potentially reduces the cost of producing high-purity chemical compounds ^[1].

"The results demonstrate the potential of biocatalysis for producing complex chiral molecules with high efficiency," said a University of Cambridge press release ^[3].